Patient-Specific 3D Action Observation Training in Parkinson's Disease
Recruiting · NCT07250672 · Interventional (participants receive a specific treatment) · Lead sponsor: Abant Izzet Baysal University
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Although studies exist demonstrating the effects of single-session action observation training on bradykinesia in patients with Parkinson's disease, research investigating the long-term application of such training remains limited. Furthermore, the broader literature indicates that action observation training has typically been conducted in simulated environments or by using recordings obtained from healthy individuals. The aim of the present study is to examine the effects of action observation training, delivered in a fully immersive virtual reality environment using each patient's own 3D motion recordings, on bradykinesia and other disease-related parameters.
Who can take part
Inclusion criteria
- Voluntary agreement to participate in the study
- Clinical diagnosis of Parkinson's disease confirmed by a neurologist
- Ongoing treatment with antiparkinsonian medication
- Hoehn and Yahr (H-Y) stage ≤ 3
- Ability to walk independently
Exclusion criteria
- Presence of additional neurological disorders other than Parkinson's disease
- Change in medication dosage within the past month
- Score of ≥ 10 on the Simulator Sickness Questionnaire
- Presence of amblyopia, strabismus, or pathologies impairing focus, depth perception, or normal 3D vision
- Failure on the butterfly test of the Titmus stereotest (greater than 3,552 seconds of arc)
Where it is running
1 location listed.
- Abant Izzet Baysal University Faculty of Health Science - Bolu, Bolu, Turkey (Türkiye)